Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments Since the early days of the Covid-19 pandemic, world-class hospitals from New York to Atlanta to San Francisco struggled with shortages of basic safety equipment.…
By Pharmatrax Author
Category: Technoloy
No Comments Perhaps the best part about covering technology is the opportunity to learn about innovations as they occur. Some (most actually) never get the opportunity to…
By Pharmatrax Author
Category: Technoloy
No Comments Often, a crisis brings about a re-evaluation of basic systems. As the world wrestles with the multi-faceted impacts of COVID-19, the global supply chain has…
By Pharmatrax Author
Category: News
No Comments Researchers from Egypt, India, and the UK are studying the role of 3D printing in drug delivery systems. Their findings are detailed in the recently…
By Pharmatrax Author
Category: News
No Comments On the hunt for drugs contaminated with a likely carcinogen, the FDA initially tested and cleared generic diabetes med metformin. But now, after an independent lab…
By Pharmatrax Author
Category: News
No Comments Another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream…
By Pharmatrax Author
Category: News
No Comments The U.S Food and Drug Administration said on Wednesday it had found high levels of a possible cancer-causing impurity in some versions of the popular…
By Pharmatrax Author
Category: Technoloy
No Comments Pune-based drug discovery research company Novalead will study the effectiveness of an anti- parasitic drug in the recovery of moderately ill Covid-19 patients, according to…
By Pharmatrax Author
Category: Technoloy
No Comments insitro unveiled a $143 million Series B round on the same day that fellow machine learning company Exscientia highlighted its own $60 million Series C…
By Pharmatrax Author
Category: Technoloy
No Comments A biotech company partnering with major pharmaceutical players like Lilly on Covid-19 drug development is raising $105 million in funding to ramp up. AbCellera announced…